Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionCi Investments Inc.
Latest Disclosed Ownership130,127 shares
Latest Disclosed Value $ 13,360,139
Ci Investments Inc. reports 8.08% increase in ownership of ABL / Abbott Laboratories

On May 13, 2026 - Ci Investments Inc. filed a 13F-HR form disclosing ownership of 130,127 shares of Abbott Laboratories (DE:ABL) valued at $11,557,880 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 120,402 shares of Abbott Laboratories. This represents a change in shares of 8.08% during the quarter. The current value of the position is $9,788,153 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ABBOTT LABS COM 002824100 130,127 9,725 8.08 13,360 -11.44 0.0647
2026-02-12 2025-12-31 13F ABBOTT LABS COM 002824100 120,402 18,678 18.36 15,085 115,938.46 0.0661
2025-11-12 2025-09-30 13F ABBOTT LABS COM 002824100 101,724 -14,487 -12.47 14 -13.33 0.0495
2025-08-12 2025-06-30 13F ABBOTT LABS COM 002824100 116,211 -16,160 -12.21 16 -11.76 0.0593
2025-05-13 2025-03-31 13F ABBOTT LABS COM 002824100 132,371 -19,028 -12.57 18 0.00 0.0740
2025-02-12 2024-12-31 13F ABBOTT LABS COM 002824100 151,399 10,000 7.07 17 6.25 0.0645
2024-11-12 2024-09-30 13F ABBOTT LABS COM 002824100 141,399 32,511 29.86 16 45.45 0.0614
2024-08-12 2024-06-30 13F ABBOTT LABS COM 002824100 108,888 -2,954 -2.64 11 -8.33 0.0446
2024-05-13 2024-03-31 13F ABBOTT LABS COM 002824100 111,842 26,496 31.05 13 33.33 0.0505
2024-02-12 2023-12-31 13F ABBOTT LABS COM 002824100 85,346 16,567 24.09 9 50.00 0.0486
2023-11-13 2023-09-30 13F ABBOTT LABS COM 002824100 68,779 -6,589 -8.74 7 -25.00 0.0372
2023-08-11 2023-06-30 13F ABBOTT LABS COM 002824100 75,368 -1,233 -1.61 8 14.29 0.0415
2023-05-12 2023-03-31 13F ABBOTT LABS COM 002824100 76,601 -34,912 -31.31 8 -41.67 0.0390
2023-02-10 2022-12-31 13F ABBOTT LABS COM 002824100 111,513 6,955 6.65 12 -99.88 0.0619
2022-11-14 2022-09-30 13F ABBOTT LABS COM 002824100 104,558 -141,255 -57.46 10,117 -62.12 0.0525
2022-08-12 2022-06-30 13F ABBOTT LABS COM 002824100 245,813 -952,759 -79.49 26,708 -81.17 0.1246
2022-05-12 2022-03-31 13F ABBOTT LABS COM 002824100 1,198,572 52,154 4.55 141,863 -12.08 0.5219
2022-02-11 2021-12-31 13F ABBOTT LABS COM 002824100 1,146,418 -112,712 -8.95 161,347 8.48 0.5568
2021-11-12 2021-09-30 13F ABBOTT LABS COM 002824100 1,259,130 -261,945 -17.22 148,741 -15.65 0.5538
2021-08-13 2021-06-30 13F ABBOTT LABS COM 002824100 1,521,075 578,923 61.45 176,338 56.18 0.6464
2021-05-13 2021-03-31 13F ABBOTT LABS COM 002824100 942,152 379,374 67.41 112,907 83.23 0.4762
2021-02-09 2020-12-31 13F ABBOTT LABS COM 002824100 562,778 -45,780 -7.52 61,619 -6.96 0.2715
2020-11-09 2020-09-30 13F ABBOTT LABS COM 002824100 608,558 -572,074 -48.45 66,229 -38.65 0.3291
2020-08-07 2020-06-30 13F ABBOTT LABS COM 002824100 1,180,632 215,779 22.36 107,945 41.78 0.5753
2020-08-07 2020-03-31 13F ABBOTT LABS COM 002824100 964,853 624,659 183.62 76,137 157.66 0.4619
2020-02-11 2019-12-31 13F ABBOTT LABS COM 002824100 340,194 77,700 29.60 29,549 34.54 0.1501
2019-11-08 2019-09-30 13F ABBOTT LABS COM 002824100 262,494 169,744 183.01 21,963 181.58 0.1134
2019-08-12 2019-06-30 13F ABBOTT LABS COM 002824100 92,750 15,200 19.60 7,800 25.83 0.0434
2019-05-15 2019-03-31 13F ABBOTT LABS COM 002824100 77,550 77,550 6,199 0.0348
2018-05-11 2017-12-31 13F/A-1 ABBOTT LABS COM 002824100 0 -810 -100.00 0 -100.00
2018-05-11 2017-09-30 13F/A-1 ABBOTT LABS COM 002824100 810 0 0.00 43 10.26 0.0004
2017-11-06 2017-09-30 13F ABBOTT LABS COM 002824100 810 0 43
2017-08-10 2017-06-30 13F ABBOTT LABS COM 002824100 810 0 0.00 39 8.33 0.0004
2017-05-05 2017-03-31 13F ABBOTT LABS COM 002824100 810 0 0.00 36 16.13 0.0004
2017-02-06 2016-12-31 13F ABBOTT LABS COM 002824100 810 0 0.00 31 -8.82 0.0003
2016-11-04 2016-09-30 13F ABBOTT LABS COM 002824100 810 0 0.00 34 6.25 0.0004
2016-08-24 2016-06-30 13F/A-2 ABBOTT LABS COM 002824100 810 810 32 0.0055
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.